Literature DB >> 22211589

The microorganisms in chronically infected end-stage and non-end-stage cystic fibrosis patients.

Vibeke B Rudkjøbing1, Trine R Thomsen, Morten Alhede, Kasper N Kragh, Per H Nielsen, Ulla R Johansen, Michael Givskov, Niels Høiby, Thomas Bjarnsholt.   

Abstract

Patients suffering from cystic fibrosis (CF) develop chronic lung infections because of highly viscous mucus, where bacteria can form biofilms. In this study, we investigated the microorganisms present in the lungs of end-stage and non-end-stage patients using standard culturing techniques and molecular methods. Tissue and sputum samples (n = 34) from explanted lungs of five end-stage patients were examined along with routine expectorates (n = 15) from 13 patients with non-end-stage CF, representing earlier stages of chronic lung infections. Previously, using peptide nucleic acid (PNA) fluorescence in situ hybridization (FISH), we have shown that Pseudomonas aeruginosa was the sole pathogen in end-stage CF lungs (Pediatr Pulmonol 2009, 44: 547). In this study, this tendency was supported by the results of real-time PCR, confirming previous results obtained by standard culturing and 16S rRNA gene analysis (J Clin Microbiol 2011, 49: 4352). Conversely, the non-end-stage patients were found to harbor several species by culturing. PNA FISH confirmed heterogeneous microbiota and showed that the bacteria were located in monospecies aggregates with no apparent physical interaction between the different microcolonies. In conclusion, standard culturing identifies the dominating pathogens, which seem to reside in monospecies microcolonies. The possibility of signaling between the distinct microcolonies still has to be verified and elucidated.
© 2011 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22211589     DOI: 10.1111/j.1574-695X.2011.00925.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  22 in total

Review 1.  The role of the bacterial microbiome in lung disease.

Authors:  Robert P Dickson; John R Erb-Downward; Gary B Huffnagle
Journal:  Expert Rev Respir Med       Date:  2013-06       Impact factor: 3.772

2.  Pseudomonas aeruginosa Can Inhibit Growth of Streptococcal Species via Siderophore Production.

Authors:  Jessie E Scott; Kewei Li; Laura M Filkins; Bin Zhu; Sherry L Kuchma; Joseph D Schwartzman; George A O'Toole
Journal:  J Bacteriol       Date:  2019-03-26       Impact factor: 3.490

Review 3.  Cystic Fibrosis Airway Microbiome: Overturning the Old, Opening the Way for the New.

Authors:  George A O'Toole
Journal:  J Bacteriol       Date:  2018-01-24       Impact factor: 3.490

Review 4.  How can the cystic fibrosis respiratory microbiome influence our clinical decision-making?

Authors:  Geraint B Rogers; Kenneth D Bruce; Lucas R Hoffman
Journal:  Curr Opin Pulm Med       Date:  2017-11       Impact factor: 3.155

5.  Cooperativity between Stenotrophomonas maltophilia and Pseudomonas aeruginosa during Polymicrobial Airway Infections.

Authors:  Melissa S McDaniel; Trenton Schoeb; W Edward Swords
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

Review 6.  Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

7.  Quality Control in Diagnostic Fluorescence In Situ Hybridization (FISH) in Microbiology.

Authors:  Judith Kikhney; Annette Moter
Journal:  Methods Mol Biol       Date:  2021

Review 8.  The pediatric microbiome and the lung.

Authors:  Michael Tracy; Jonathan Cogen; Lucas R Hoffman
Journal:  Curr Opin Pediatr       Date:  2015-06       Impact factor: 2.856

9.  A temporal examination of the planktonic and biofilm proteome of whole cell Pseudomonas aeruginosa PAO1 using quantitative mass spectrometry.

Authors:  Amber J Park; Kathleen Murphy; Jonathan R Krieger; Dyanne Brewer; Paul Taylor; Marc Habash; Cezar M Khursigara
Journal:  Mol Cell Proteomics       Date:  2014-02-16       Impact factor: 5.911

Review 10.  Directly sampling the lung of a young child with cystic fibrosis reveals diverse microbiota.

Authors:  Perry S Brown; Christopher E Pope; Robyn L Marsh; Xuan Qin; Sharon McNamara; Ronald Gibson; Jane L Burns; Gail Deutsch; Lucas R Hoffman
Journal:  Ann Am Thorac Soc       Date:  2014-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.